KAITLYN GUIMOND: Open Payments
NPI 1861933145 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,940 in 98 payments from 15 companies in 2025. Trend: 2023 $1,038 · 2024 $2,368 · 2025 $1,940
Food & beverage: $1,940
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $572 |
| Incyte Corporation | 8 | $242 |
| Novartis Pharmaceuticals Corporation | 9 | $201 |
| UCB, Inc. | 12 | $179 |
| E.R. Squibb & Sons, L.L.C. | 10 | $158 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $147 |
| Lilly USA, LLC | 3 | $132 |
| Janssen Biotech, Inc. | 6 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| LEO Pharma Inc. | 2 | $35 |
Products named: SKYRIZI, Opzelura, Bimzelx, RINVOQ, Sotyktu, COSENTYX, ILUMYA, EBGLYSS.
Industry payments across KS — which companies pay providers there.
